Journal article
The UCEIS and UC-100 score were responsive endoscopic and global indices in a phase 2 trial of ulcerative colitis
- Abstract:
- Lay Summary: This post hoc analysis of a phase 2 placebo-controlled trial of mirikizumab found that the Ulcerative Colitis Endoscopic Index of Severity and the composite UC-100 score were responsive to changes in endoscopic and global ulcerative colitis disease activity, respectively.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.1MB, Terms of use)
-
- Publisher copy:
- 10.1093/crocol/otag031
Authors
- Publisher:
- Oxford University Press
- Journal:
- Crohn's & Colitis 360 More from this journal
- Volume:
- 8
- Issue:
- 2
- Pages:
- otag031
- Article number:
- otag031
- Publication date:
- 2026-04-24
- Acceptance date:
- 2026-01-19
- DOI:
- EISSN:
-
2631-827X
- ISSN:
-
2631-827X
- Language:
-
English
- Keywords:
- Source identifiers:
-
4074844
- Deposit date:
-
2026-05-23
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record